WO1997022628A1 - Inhibiteur d'epaississement de la membrane intravasculaire - Google Patents
Inhibiteur d'epaississement de la membrane intravasculaire Download PDFInfo
- Publication number
- WO1997022628A1 WO1997022628A1 PCT/JP1996/003662 JP9603662W WO9722628A1 WO 1997022628 A1 WO1997022628 A1 WO 1997022628A1 JP 9603662 W JP9603662 W JP 9603662W WO 9722628 A1 WO9722628 A1 WO 9722628A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- sulfated polysaccharide
- fucose
- sea cucumber
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96941879A EP0811635B1 (en) | 1995-12-20 | 1996-12-16 | Intravascular membrane thickening inhibitor |
AU11111/97A AU700986B2 (en) | 1995-12-20 | 1996-12-16 | Vascular intimal hypasplasia-inhibitory composition |
DE69624558T DE69624558T2 (de) | 1995-12-20 | 1996-12-16 | Inhibitor der eindickung der intravaskulären membran |
US08/894,366 US5993797A (en) | 1995-12-20 | 1996-12-16 | Vascular intimal hyperplasia-inhibitory composition |
JP52265897A JP3455783B2 (ja) | 1995-12-20 | 1996-12-16 | 血管内膜肥厚抑制剤 |
CA002212458A CA2212458C (en) | 1995-12-20 | 1996-12-16 | Vascular intimal hyperplasia-inhibitory composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33175895 | 1995-12-20 | ||
JP7/331758 | 1995-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997022628A1 true WO1997022628A1 (fr) | 1997-06-26 |
Family
ID=18247297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1996/003662 WO1997022628A1 (fr) | 1995-12-20 | 1996-12-16 | Inhibiteur d'epaississement de la membrane intravasculaire |
Country Status (8)
Country | Link |
---|---|
US (1) | US5993797A (ja) |
EP (1) | EP0811635B1 (ja) |
JP (1) | JP3455783B2 (ja) |
KR (1) | KR100240544B1 (ja) |
AU (1) | AU700986B2 (ja) |
CA (1) | CA2212458C (ja) |
DE (1) | DE69624558T2 (ja) |
WO (1) | WO1997022628A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPO888497A0 (en) * | 1997-09-01 | 1997-09-25 | Australian National University, The | Use of sulfated oligosaccharides as inhibitors of cardiovascular disease |
US6518244B2 (en) | 2000-03-09 | 2003-02-11 | Intimax Corporation | Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof |
US6916492B2 (en) | 2001-03-30 | 2005-07-12 | Council Of Scientific & Industrial Research | Natural nontoxic multicolor fluorescent protein dye from a marine invertebrate, compositions containing the said dye and its uses |
US6689391B2 (en) | 2001-03-30 | 2004-02-10 | Council Of Scientific & Industrial Research | Natural non-polar fluorescent dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses |
US7892218B2 (en) * | 2004-03-03 | 2011-02-22 | Rostam Ltd. | pH reducing formulation |
CN101724086B (zh) * | 2009-11-25 | 2012-09-26 | 深圳海王药业有限公司 | 低聚凤梨参糖胺聚糖及其制备方法 |
WO2014153995A1 (zh) | 2013-03-26 | 2014-10-02 | 中国科学院昆明植物研究所 | 一种低分子量糖胺聚糖衍生物及其药物组合物和其制备方法与应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0491027A (ja) * | 1990-08-02 | 1992-03-24 | Taiho Yakuhin Kogyo Kk | 抗ヒト免疫不全症ウィルス剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2087907T3 (es) * | 1989-02-06 | 1996-08-01 | Taiho Pharmaceutical Co Ltd | Nuevo polisacarido sulfatado, sales farmaceuticamente aceptables del mismo, procedimiento para prepararlos y medicamento que los contiene como ingrediente activo. |
US5519010A (en) * | 1989-02-06 | 1996-05-21 | Taiho Pharmaceutical Co., Ltd. | Sulfated polysaccharide, pharmaceutically acceptable salt thereof, process for preparing same and medicament containing same as effective component |
AU620218B2 (en) * | 1989-02-10 | 1992-02-13 | Taiho Pharmaceutical Co., Ltd. | Anti-hiv drug |
US5646130A (en) * | 1995-06-30 | 1997-07-08 | Ocean University Of Oingdao | Low molecular weight sulfated polysaccharides and uses thereof |
US5770205A (en) * | 1996-08-05 | 1998-06-23 | Coastside Bio Resources | Tissue fractions of sea cucumber for the treatment of inflammation |
-
1996
- 1996-12-16 CA CA002212458A patent/CA2212458C/en not_active Expired - Fee Related
- 1996-12-16 US US08/894,366 patent/US5993797A/en not_active Expired - Fee Related
- 1996-12-16 WO PCT/JP1996/003662 patent/WO1997022628A1/ja active IP Right Grant
- 1996-12-16 JP JP52265897A patent/JP3455783B2/ja not_active Expired - Fee Related
- 1996-12-16 EP EP96941879A patent/EP0811635B1/en not_active Expired - Lifetime
- 1996-12-16 AU AU11111/97A patent/AU700986B2/en not_active Ceased
- 1996-12-16 KR KR1019970705721A patent/KR100240544B1/ko not_active IP Right Cessation
- 1996-12-16 DE DE69624558T patent/DE69624558T2/de not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0491027A (ja) * | 1990-08-02 | 1992-03-24 | Taiho Yakuhin Kogyo Kk | 抗ヒト免疫不全症ウィルス剤 |
Also Published As
Publication number | Publication date |
---|---|
CA2212458C (en) | 2001-08-28 |
US5993797A (en) | 1999-11-30 |
DE69624558T2 (de) | 2003-07-10 |
KR100240544B1 (ko) | 2000-01-15 |
JP3455783B2 (ja) | 2003-10-14 |
EP0811635A1 (en) | 1997-12-10 |
DE69624558D1 (de) | 2002-12-05 |
CA2212458A1 (en) | 1997-06-26 |
AU700986B2 (en) | 1999-01-14 |
AU1111197A (en) | 1997-07-14 |
EP0811635B1 (en) | 2002-10-30 |
KR19980702324A (ko) | 1998-07-15 |
EP0811635A4 (en) | 1999-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2762522B2 (ja) | 血管新生阻害剤 | |
JP2806454B2 (ja) | 脈管形成阻止剤 | |
US4533549A (en) | Antithrombotic agent | |
US20100256090A1 (en) | Alginic Acid with Low Molecular Weight, Its Salts, Uses, Preparative Methods, Pharmaceutical Compositions and Foods | |
US20090105194A1 (en) | Process for the production of a low molecular weight heparin | |
JP2003523460A (ja) | 抗脈管形成活性を有し、かつ、抗凝固作用がない、部分脱硫酸グリコサミノグリカンの誘導体 | |
JP3714426B2 (ja) | フコイダンオリゴ糖組成物含有癌転移抑制剤 | |
WO2000053194A1 (fr) | Medicaments contre les affections articulaires | |
JP6662503B2 (ja) | ポリ硫酸ペントサン及びポリ硫酸ペントサンを含む医薬 | |
WO1997022628A1 (fr) | Inhibiteur d'epaississement de la membrane intravasculaire | |
KR960010438B1 (ko) | 항-hiv제 | |
JP2714718B2 (ja) | 新規硫酸化多糖及びその薬学的に許容される塩、その製造方法並びにそれを有効成分とする医薬 | |
JP4201360B2 (ja) | 炭水化物誘導体 | |
JP4450456B2 (ja) | 皮脂産生抑制剤 | |
JPH02223525A (ja) | 血管新生阻害剤 | |
EP0448029A2 (en) | Novel pharmaceutical uses of forskolin derivatives | |
JPS6049164B2 (ja) | 血漿増量剤 | |
WO2002083155A1 (en) | Use of sulfated bacterial polysaccharides suitable for the inhibition of angiogenesis | |
JP4530633B2 (ja) | シグナル伝達物質産生抑制剤 | |
KR20010040752A (ko) | 에이즈 치료제 | |
JPH11310588A (ja) | 新規な血小板粘着凝集抑制物質、その製造法およびその用途 | |
JPH10265503A (ja) | 骨格筋成長剤 | |
JP4341970B2 (ja) | フコイダンオリゴ糖組成物含有抗真菌剤 | |
JPH06287142A (ja) | 抗hiv剤 | |
JPH07179349A (ja) | コンドロイチン硫酸のアシル誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref document number: 2212458 Country of ref document: CA Kind code of ref document: A Ref document number: 2212458 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996941879 Country of ref document: EP Ref document number: 08894366 Country of ref document: US Ref document number: 1019970705721 Country of ref document: KR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1996941879 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970705721 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019970705721 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996941879 Country of ref document: EP |